1 |
Bombardieri M, McInnes IB, Pitzalis C (2007). Interleukin-18 as a potential therapeutic target in chronic autoimmune/inflammatory conditions. Expert Opin Biol Th, 7, 31-40.
DOI
ScienceOn
|
2 |
Chan AT, Teo PM, Johnson PJ (2002). Nasopharyngeal carcinoma. Ann Oncol, 13, 1007-15.
DOI
ScienceOn
|
3 |
Cochran WG (1968). The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics, 24, 295-313.
DOI
ScienceOn
|
4 |
DeSantis C, Naishadham D, Jemal A (2013). Cancer statistics for African Americans, 2013. CA-Cancer J Clin, 63,151-66.
DOI
ScienceOn
|
5 |
Dinarello CA, Novick D, Kim S, Kaplanski G (2013). Interleukin-18 and IL-18 Binding Protein. Front Immunol, 4, 289.
|
6 |
Du B, Zhao J, Wei Y (2012). Interleukin-18 gene genetic polymorphisms and risk Of nasopharyngeal carcinoma in Han population from Sichuan China. Med J West China, 25, 1683-6.
|
7 |
Egger M, Smith G, Schneider M, Minder C. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
DOI
ScienceOn
|
8 |
Farhat K, Hassen E, Bouzgarrou N, et al (2008). Functional IL-18 promoter gene polymorphisms in Tunisian nasopharyngeal carcinoma patients. Cytokine, 43, 132-7.
DOI
ScienceOn
|
9 |
Fariasa TD, Canto LM, Medeiros MD, et al (2013). Lack of association between interleukin-18 polymorphisms and rheumatoid arthritis. Rev Bras Reumatol, 53, 199-205.
DOI
|
10 |
Jemal A, Bray F, Center MM, et al (2011). Global Cancer Statistics. CA-Cancer J Clin, 61, 69-90.
DOI
|
11 |
Ji J, Lee W (2013). Interleukin-18 gene polymorphisms and rheumatoid arthritis: A meta-analysis. Gene, 523, 27-32.
DOI
ScienceOn
|
12 |
Ma Y, Zhang B, Tang R, et al (2012). Interleukin-18 promoter polymorphism and asthma risk: a meta-analysis. Mol Biol Rep, 39, 1371-6.
DOI
|
13 |
Mantel N, Haensze W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer I, 22, 719-48.
|
14 |
Mi Y, Yu Q, Yu M, et al (2011). Review and pooled analysis of studies on -607 (C/A) and -137 (G/C) polymorphisms in IL-18 and cancer risk. Med Oncol, 28, 1107-15.
DOI
ScienceOn
|
15 |
Nong L, Luo B, Zhang L, Nong H (2009). Interleukin-18 gene promoter polymorphism and the risk of nasopharyngeal carcinoma in a Chinese population. DNA Cell Biol, 28, 507-13.
DOI
ScienceOn
|
16 |
Pan G, Luo B, Teng Y, Liang L (2013). Research on interleukin-18 gene promotoe polymorphisms and genetic susceptibility of nasopharngeal carcinoma. Lab Med, 28, 457-61.
|
17 |
Pratesi C, Bortolin MT, Bidoli E, et al (2006). Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type. Cancer Immunol Immun, 55,23-30.
DOI
ScienceOn
|
18 |
Song G, Bae S, Kim J, Lee Y (2013). Interleukin-4, interleukin-4 receptor, and interleukin-18 polymorphisms and rheumatoid arthritis: a meta-analysis. Immunol Invest, 42, 455-69.
DOI
ScienceOn
|
19 |
Srivastava S, Salim N, and Robertson MJ (2010). Interleukin-18: Biology and Role in the Immunotherapy of Cancer. Curr Med Chem, 17, 3353-7.
DOI
ScienceOn
|
20 |
Song G, Choi S, Ji J, Lee Y (2013). Association between interleukin-18 polymorphisms and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep, 40, 2581-7.
DOI
ScienceOn
|
21 |
Stuck AE, Rubenstein LZ, and Wieland D (1998). Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ, 316, 469
DOI
ScienceOn
|
22 |
Thakkinstian A, McElduff P, Este C, et al (2005). A method for meta-analysis of molecular association studies. Stat Med, 24, 1291-306.
DOI
ScienceOn
|
23 |
Wang M, Zhu X, Wang L, Lin Y (2013). The -607C/A Polymorphisms in Interleukin-18 Gene Promoter Contributes to Cancer Risk: Evidence from A Meta-Analysis of 22 Case-Control Studies. Plos One, 8, e76915.
DOI
|
24 |
Yang X, Qiu M, Hu J, et al (2013). Association of interleukin-18 gene promoter -607 C>A and -137G>C polymorphisms with cancer risk: a meta-analysis of 26 studies. Plos One, 8, e73671.
DOI
|
25 |
Yang Y, Chang T, Chen T, et al (2013). Genetic variants in interleukin-18 gene and risk for cervical squamous cell carcinoma. Hum Immunol, 74, 882-7.
DOI
ScienceOn
|